Overview
- President Claudia Sheinbaum said Health and Economy officials are analyzing mechanisms to lower costs, with priority on patented medicines.
- The government is meeting with pharmaceutical companies and drug distributors to address what it calls excessive prices in private pharmacies and hospitals.
- The national antitrust authority has been tapped to ensure sufficient competition and to deter practices that unjustifiably raise prices.
- Teams are reviewing market behavior and cost structures, including why some drugs stay costly even when the peso strengthens against the dollar.
- Public clinics are to keep supplying medicines free of charge, and specific measures for the private market will be announced after the evaluation phase.